(1 - 16 from 17
)
Immunotherapy agent benefits patients with drug-resistant multiple...
www.dana-farber.org
A breakthrough immunotherapy agent produced at least partial remissions in a third of clinical trial patients with multiple myeloma who had exhausted multiple...
Myeloma Therapy Candidate CellProtect Receives EU Orphan Drug Status
myelomaresearchnews.com
The European Commission has granted orphan drug designation to CellProtect, made of a group of NK immune cells, as a treatment for multiple myeloma.
sorted by relevance / date